SCHEMBL23487150

SCHEMBL23487150

CCC1CC(C(=O)OC)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GAA P10253 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ OPRK1 P41145 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PTPN2 P17706 1/20 0.38
▸ PTPN1 P18031 1/20 0.38
▸ PTPN6 P29350 1/20 0.38
▸ CHRM2 P08172 1/20 0.37
▸ CHRM1 P11229 1/20 0.37
▸ CHRM3 P20309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31320075 1.00 SMN1; SMN2 (0.41) SMN1; SMN2HSD17B10HPGDGAAALDH1A1
SCHEMBL23695127 0.93 HSD17B10 (0.41) SMN1; SMN2HSD17B10HPGDALDH1A1MEN1
SCHEMBL23695128 0.93 HSD17B10 (0.41) SMN1; SMN2HSD17B10HPGDALDH1A1MEN1
SCHEMBL7841633 0.90 ATM (0.39) SMN1; SMN2HSD17B10HPGDGAAALDH1A1
SCHEMBL24047701 0.87 HSD17B10 (0.50) SMN1; SMN2HSD17B10HPGDALDH1A1RECQL
SCHEMBL1439128 0.87 HSD17B10 (0.50) SMN1; SMN2HSD17B10HPGDALDH1A1RECQL
SCHEMBL26430589 0.87 HSD17B10 (0.50) SMN1; SMN2HSD17B10HPGDALDH1A1RECQL
SCHEMBL31008158 0.87 SMN1; SMN2 (0.38) SMN1; SMN2HSD17B10HPGDGAAALDH1A1
SCHEMBL31320051 0.85 SMN1; SMN2 (0.39) SMN1; SMN2HSD17B10HPGDKMT2ARECQL
SCHEMBL24962291 0.83 SMN1; SMN2 (0.35) SMN1; SMN2HSD17B10HPGDALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688741-A1 COMPOUNDS FOR TREATING FIBROTIC DISEASES Meta-Immune, Inc. (KR) 2026-02-11 — — EP disclosed
WO-2024249867-A1 COMPOUNDS FOR TREATING FIBROTIC DISEASES AM SCIENCES (KR) 2024-12-05 — — WO disclosed
EP-4289839-A1 NOVEL AURORA KINASE INHIBITOR AND USE THEREOF Wigen Biomedicine Technology (Shanghai) Co., Ltd. (CN) 2023-12-13 — — EP disclosed
WO-2023184327-A1 KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF InventisBio Co., Ltd. (CN) 2023-10-05 — — WO disclosed
WO-2021110009-A1 NOVEL AURORA KINASE INHIBITOR AND USE THEREOF 微境生物医药科技(上海)有限公司 2021-06-10 — — WO disclosed
Send feedback